Wilmington Savings Fund Society FSB cut its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 25.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,240 shares of the medical instruments supplier’s stock after selling 2,407 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in DENTSPLY SIRONA were worth $137,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also modified their holdings of the company. State of Alaska Department of Revenue boosted its holdings in DENTSPLY SIRONA by 2.4% during the 3rd quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock valued at $637,000 after acquiring an additional 560 shares during the period. UMB Bank n.a. boosted its holdings in DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 564 shares during the period. MML Investors Services LLC raised its position in DENTSPLY SIRONA by 2.1% in the 3rd quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock valued at $803,000 after purchasing an additional 620 shares in the last quarter. Allworth Financial LP raised its position in DENTSPLY SIRONA by 40.2% in the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 625 shares in the last quarter. Finally, Blue Trust Inc. raised its position in DENTSPLY SIRONA by 10.9% in the 4th quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock valued at $137,000 after purchasing an additional 707 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
XRAY has been the topic of a number of analyst reports. Mizuho initiated coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price target on the stock. Morgan Stanley reduced their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Barrington Research reduced their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday, November 8th. Jefferies Financial Group lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating and reduced their price target for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Finally, StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, February 7th. Nine equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, DENTSPLY SIRONA has an average rating of “Hold” and an average target price of $26.33.
DENTSPLY SIRONA Trading Up 0.5 %
NASDAQ:XRAY opened at $18.37 on Thursday. The stock’s 50 day moving average price is $19.04 and its 200 day moving average price is $22.04. The company has a market capitalization of $3.65 billion, a PE ratio of -8.87, a P/E/G ratio of 1.83 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 52-week low of $17.21 and a 52-week high of $34.91.
DENTSPLY SIRONA Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a yield of 3.48%. DENTSPLY SIRONA’s dividend payout ratio is presently -30.92%.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Recommended Stories
- Five stocks we like better than DENTSPLY SIRONA
- Why Are These Companies Considered Blue Chips?
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Roth IRA Calculator: Calculate Your Potential Returns
- Inflation Persists, But So Do Stock Opportunities: Rally On
- About the Markup Calculator
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.